Search for an orphan drug
Other search option(s)
Marketing authorisation with orphan designation - Europe
- Tradename: DACOGEN
- ATC code : L01BC08
- EU Number: EMEA/H/C/2221/IB/26
- MA date : 30/06/2016
- MA holder: JANSSEN-CILAG INTERNATIONAL NV
- European Public Assessment Report
Therapeutic indication
Treatment of adult patients with newly diagnosed de novo or secondary acute myeloid leukaemia (AML), according to the World Health Organisation (WHO) classification, who are not candidates for standard induction chemotherapy.
Diseases list
Appraisal/reimbursement
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.